Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Castleman disease is not a single condition but a group of rare lymphoproliferative disorders characterized by immune system dysregulation, where the body’s inflammatory response is essentially "stuck in the on position." While the exact cause remains unknown for most patients, research points to a combination of cytokine overproduction—specifically interleukin-6 (IL-6)—and potential viral triggers or immune system malfunctions. What causes Castleman disease? The core mechanism of Castleman disease involves the overproduction of cytokines, which are small proteins that act as messengers for the immune system. In many patients, an excess of IL-6 leads to the abnormal growth of lymph nodes and systemic inflammatory symptoms.
TL;DR: Castleman disease is not a single condition but a group of rare lymphoproliferative disorders characterized by immune system dysregulation, where the body’s inflammatory response is essentially "stuck in the on position." While the exact cause remains unknown for most patients, research points to a combination of cytokine overproduction—specifically interleukin-6 (IL-6)—and potential viral triggers or immune system malfunctions.
The core mechanism of Castleman disease involves the overproduction of cytokines, which are small proteins that act as messengers for the immune system. In many patients, an excess of IL-6 leads to the abnormal growth of lymph nodes and systemic inflammatory symptoms. Think of it like a thermostat that is broken; the body continues to send "firefighter" immune cells to areas where there is no actual fire, leading to the characteristic tissue growth seen in Castleman disease.
Current clinical evidence suggests that Castleman disease is generally not an inherited genetic condition. Unlike many rare diseases caused by a single gene mutation, researchers have not identified a specific "Castleman gene" passed down through families. Instead, Castleman disease is often considered an acquired condition, meaning the immune system dysregulation develops during a person's lifetime rather than being present at birth.
The etiology of Castleman disease varies significantly depending on the subtype:
Medical researchers are currently focused on identifying the specific molecular pathways that cause the immune system to misfire in Castleman disease. With 59 community members on DiseaseMaps.org sharing their experiences, patient-led data is helping scientists distinguish between different subtypes, which is essential for developing targeted therapies that block the specific cytokines driving the disease.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult a qualified healthcare provider regarding your specific diagnosis.